ClosedPublished 27 Apr 2026

XOMA Royalty Corporation /
Generation Bio

XOMA Royalty completes Generation Bio acquisition

Buy side: XOMA Royalty Corporation
Buy sideXOMA Royalty Corporation
Target: Generation Bio
TargetGeneration Bio
XOMA Royalty Corp · 27 Apr 2026Source
Buy side: XOMA Royalty Corporation
Buy sideXOMA Royalty Corporation
Target: Generation Bio
TargetGeneration Bio
01 / BuyerXOMA Royalty Corporation
02 / TargetGeneration Bio
Source for the buyer and target: XOMA Royalty Corp

For the buyer and target.

“As previously disclosed, XOMA Royalty Corporation (“ XOMA Royalty ”) entered into an Agreement and Plan of Merger, dated December 15, 2025 (the “ Merger Agreement ”), with Generation Bio Co., a Delaware corporation (the “ Company ” or “ Generation Bio ”), and XRA 7 Corp., a Delaware corporation and a wholly owned subsidiary of XOMA Royalty (“ Merger Sub ”).”

Published 27 Apr 2026

Open the source
01

What happened

XOMA Royalty has completed its acquisition of Generation Bio, carried out through a tender offer followed by a merger in which Generation Bio became a wholly owned subsidiary. Holders received a cash amount per share plus one contingent value right for each share. [01]

XOMA Royalty acquired Generation Bio's remaining cash, certain tax deductions and legacy lipid nanoparticle assets, and it does not plan to continue preclinical development of those assets. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · XOMA Royalty Corp

XOMA Royalty completes Generation Bio acquisition

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by XOMA Royalty Corp

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.